T. MORIYAMA, T. KANEKO, M. FUJII, Y. TSUBAKIHARA, S. KAWANO, E. IMAI
{"title":"日本膜性肾病患者幽门螺杆菌感染高发","authors":"T. MORIYAMA, T. KANEKO, M. FUJII, Y. TSUBAKIHARA, S. KAWANO, E. IMAI","doi":"10.1111/j.1746-6342.2006.00044.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Summary</h3>\n </section>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases such as infection, neoplasm, and autoimmune conditions. Recently, the <i>Helicobacter pylori</i> antigen was detected histochemically in the glomeruli of membranous nephropathy patients, raising the possibility that <i>H. pylori</i> may be the pathogen that causes.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>To reveal the p1revalence of <i>H. pylori</i> infection in the Japanese membranous nephropathy population and to test the therapeutic efficacy of <i>H. pylori</i> eradication on the course of disease in membranous nephropathy patients.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The prevalence of <i>H. pylori</i> infection was investigated by the HM-CAP method in 32 membranous nephropathy patients and an age-matched control group (C: <i>n</i> = 243).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A significantly higher <i>H. pylori</i> infection rate was found in membranous nephropathy patients than in the control group (positive/total: membranous nephropathy 21/32 vs. C 108/243, <i>P</i> < 0.05 by chi-squared test). Eradication of <i>H. pylori</i> was achieved in four membranous nephropathy patients with proteinuria who were receiving glucocorticoid therapy, three of whom experienced a reduction of proteinuria after eradication.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>We found a higher prevalence of <i>H. pylori</i> infection in Japanese membranous nephropathy patients than in age-matched control subjects, which suggests the possible involvement of <i>H. pylori</i> infection in the pathogenesis of membranous nephropathy.</p>\n </section>\n </div>","PeriodicalId":50822,"journal":{"name":"Alimentary Pharmacology & Therapeutics Symposium Series","volume":"2 1","pages":"189-193"},"PeriodicalIF":0.0000,"publicationDate":"2006-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1746-6342.2006.00044.x","citationCount":"0","resultStr":"{\"title\":\"High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy\",\"authors\":\"T. MORIYAMA, T. KANEKO, M. FUJII, Y. TSUBAKIHARA, S. KAWANO, E. IMAI\",\"doi\":\"10.1111/j.1746-6342.2006.00044.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <section>\\n \\n <h3> Summary</h3>\\n </section>\\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases such as infection, neoplasm, and autoimmune conditions. Recently, the <i>Helicobacter pylori</i> antigen was detected histochemically in the glomeruli of membranous nephropathy patients, raising the possibility that <i>H. pylori</i> may be the pathogen that causes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>To reveal the p1revalence of <i>H. pylori</i> infection in the Japanese membranous nephropathy population and to test the therapeutic efficacy of <i>H. pylori</i> eradication on the course of disease in membranous nephropathy patients.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>The prevalence of <i>H. pylori</i> infection was investigated by the HM-CAP method in 32 membranous nephropathy patients and an age-matched control group (C: <i>n</i> = 243).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A significantly higher <i>H. pylori</i> infection rate was found in membranous nephropathy patients than in the control group (positive/total: membranous nephropathy 21/32 vs. C 108/243, <i>P</i> < 0.05 by chi-squared test). Eradication of <i>H. pylori</i> was achieved in four membranous nephropathy patients with proteinuria who were receiving glucocorticoid therapy, three of whom experienced a reduction of proteinuria after eradication.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>We found a higher prevalence of <i>H. pylori</i> infection in Japanese membranous nephropathy patients than in age-matched control subjects, which suggests the possible involvement of <i>H. pylori</i> infection in the pathogenesis of membranous nephropathy.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50822,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics Symposium Series\",\"volume\":\"2 1\",\"pages\":\"189-193\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1746-6342.2006.00044.x\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics Symposium Series\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2006.00044.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics Symposium Series","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1746-6342.2006.00044.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy
Summary
Background
Membranous nephropathy is the most common cause of nephrotic syndrome in Japanese adults, and is often precipitated by systemic diseases such as infection, neoplasm, and autoimmune conditions. Recently, the Helicobacter pylori antigen was detected histochemically in the glomeruli of membranous nephropathy patients, raising the possibility that H. pylori may be the pathogen that causes.
Aim
To reveal the p1revalence of H. pylori infection in the Japanese membranous nephropathy population and to test the therapeutic efficacy of H. pylori eradication on the course of disease in membranous nephropathy patients.
Methods
The prevalence of H. pylori infection was investigated by the HM-CAP method in 32 membranous nephropathy patients and an age-matched control group (C: n = 243).
Results
A significantly higher H. pylori infection rate was found in membranous nephropathy patients than in the control group (positive/total: membranous nephropathy 21/32 vs. C 108/243, P < 0.05 by chi-squared test). Eradication of H. pylori was achieved in four membranous nephropathy patients with proteinuria who were receiving glucocorticoid therapy, three of whom experienced a reduction of proteinuria after eradication.
Conclusions
We found a higher prevalence of H. pylori infection in Japanese membranous nephropathy patients than in age-matched control subjects, which suggests the possible involvement of H. pylori infection in the pathogenesis of membranous nephropathy.